Deciphera Pharmaceuticals, Inc. Proceeds from Issuance Initial Public Offering
Deciphera Pharmaceuticals, Inc. reported Proceeds from Issuance Initial Public Offering of $129.11 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2018-03-28
- Deciphera Pharmaceuticals, Inc. proceeds from issuance initial public offering for fiscal 2017 was $129.11M.
| Period end | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|
| 2017-12-31 | $129.11M 10-K · filed 2018-03-28 |